We observed that the NFKB1-94 ins/del polymorphism was associated with decreased risk of prostate cancer in both heterozygous and homozygous comparison models, suggesting that the variant del allele may be linked to a reduced inflammatory status among its carriers and, therefore, a reduced risk. This evidence concerns the gene NFKB1 and Familial prostate cancer.